GlassScriptPhysician profile
Bindu Naran Patel
NPI 1639518913
$381.32
in general payments reported to CMS, 2019-2025
13 companies · $97.11 in 2025
The $97.11 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $205 · 2020: $78.95 · 2025: $97.11.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $97.11.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $97.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $97.11 | 2025 | |
| Daiichi Sankyo INC. | $45.33 | 2019-2020 | |
| Therapeuticsmd, INC. | $41.76 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $30.15 | 2019 | |
| Abbvie INC. | $28.00 | 2019 | |
| Lupin INC. | $24.79 | 2019-2020 | |
| Hologic Sales and Service, LLC | $24.32 | 2019 | |
| Amag Pharmaceuticals, INC. | $18.15 | 2019 | |
| Roche Diagnostics Corporation | $17.75 | 2019 | |
| Boston Scientific Corporation | $15.34 | 2019 | |
| Exeltis, USA INC. | $14.13 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $12.44 | 2020 | |
| Avanos Medical | $12.05 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bindu Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.